Can one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonists
Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide significant benefits for cardiovascular, kidney, liver, joint, and sleep-related diseases. These effects extend…